Bullseye Asset Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Bullseye Asset Management's NEO Position: Q2 2026 in Review
Bullseye Asset Management increased its NeoGenomics (NEO) stake by 0.67% in Q2 2026, buying an estimated $15.3K and bringing the position to 238,443 shares worth $3.48M. The position accounts for 1.77% of the portfolio, ranked #26.
Bullseye Asset Management first reported a position in NEO in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.85M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Bullseye Asset Management held 238,443 shares of NeoGenomics worth $3.48M as of Q2 2026.
- Bullseye Asset Management bought 1,583 NeoGenomics shares in Q2 2026, an estimated $15.3K.
- NeoGenomics made up 1.77% of Bullseye Asset Management's portfolio in Q2 2026, its #26 holding.
- Bullseye Asset Management first reported a position in NeoGenomics in Q4 2019 and has held it in 27 quarters since.
- Bullseye Asset Management's NeoGenomics position peaked at $5.85M in Q4 2020.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Bullseye Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.